Raul Arroyo, MD
Urology · Arecibo, PRNPI 1104926807
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,410 of the $3,748 with a category attached, or 64.3%. 15 manufacturers reported payments, led by Teleflex LLC at 37.6% of the total. Reporting peaked in 2023 at $1,138 and has fallen 69.9% since, to $342 in 2025.
Across 52 payments — averaging $72.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$1K
- Johnson & Johnson$610
- Boston Scientific$511
- Olympus Latin America, Inc.$222
- Endomagnetics Ltd$221
- Verity Pharmaceuticals Inc.$139
- plus $636 from 9 others
What the payments were for
- Travel & lodging$98926%
- Food & beverage$2,41064%
- Education$3499%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 9 | $1,408 |
| Johnson & Johnson(2 entities) | 13 | $610 |
| Boston Scientific | 10 | $511 |
| Olympus Latin America, Inc. | 2 | $222 |
| Endomagnetics Ltd | 3 | $221 |
| Verity Pharmaceuticals Inc. | 2 | $139 |
| AbbVie(2 entities) | 2 | $125 |
| Travere Therapeutics, Inc. | 2 | $118 |
| Urogen Pharma, Inc. | 1 | $114 |
| Medtronic | 1 | $106 |
| KCI USA, Inc. | 1 | $49 |
| Tolmar, Inc. | 2 | $48 |
| Pfizer | 2 | $35 |
| Pharmaand GmbH | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,748 in reported general payments places this provider in the 65th percentile of 122 urology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 70 | $47,037 |
| Lupron DepotLeuprolide Acetate | 17 | $34,191 |
| PremarinEstrogens, Conjugated | 40 | $17,778 |
| Oxybutynin Chloride ErOxybutynin Chloride | 482 | $14,560 |
| Tamsulosin Hcl | 1,022 | $12,620 |
| Finasteride | 784 | $12,011 |
| Potassium Citrate ErPotassium Citrate | 260 | $10,021 |
| Tolterodine Tartrate ErTolterodine Tartrate | 59 | $5,842 |
| Testosterone | 26 | $5,129 |
| EligardLeuprolide Acetate | 11 | $4,885 |
| Bicalutamide | 129 | $3,882 |
| NitrofurantoinNitrofurantoin Macrocrystal | 166 | $3,522 |
| Testosterone Cypionate | 31 | $2,111 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 85 | $1,906 |
| Estradiol | 12 | $1,632 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLupron Depot | $125 | $34,19117 claims |
| PfizerPremarin | $35 | $17,77840 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 122 urology providers in Puerto Rico.
Other urology in Arecibo
- Victor Otano-RiveraArecibo$6K
- Fernando Arroyo-GonzalezArecibo$3K
- Claudio Bernaschina BobadillaPonce$132K
- Mariela Martinez-RiveraPonce$105K
- Freddy Mendez TorresCayey$95K
- Luis AmbertRio Piedras$64K
- Jorge Crespo CarrilloRio Piedras$62K
- Ronald Cadillo ChavezBayamon$61K
- Andres Perez RomanSan Juan$58K
- Rafael Bouet BlasiniSan Juan$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.